| #301 |
Geracimos Rassias |
Glaxo Group Limited |
1 |
| #301 |
Aaron Tsu Tshen Chuang |
Plasticell Limited |
1 |
| #301 |
Zoe Alicia Henley |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Eric Talbot |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Jonathan Andrew Taylor |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Heather Anne Barnett |
Glaxo Group Limited |
1 |
| #301 |
Nicholas Paul Henley |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Mohammed Azad Hussain |
Imperial College Of Science, Technology And Medicine |
1 |
| #301 |
Simon Barraclough |
Airbus Defence And Space Gmbh |
1 |
| #301 |
David De-Castro Galan |
Airbus Defence And Space Gmbh |
1 |
| #301 |
Michael Batiste |
Airbus Defence And Space Gmbh |
1 |
| #301 |
Sabine JOHNSON |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Eirini VAMVA |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Salima Zarah Ismail |
Nerre Therapeutics Limited |
1 |
| #301 |
Sam Wooler |
Airbus Defence And Space Gmbh |
1 |
| #301 |
Ashley Baker |
Airbus Defence And Space Gmbh |
1 |
| #301 |
Brian Van Luipen |
Airbus Defence And Space Gmbh |
1 |
| #301 |
Smart Elvis Maumbe |
— |
1 |
| #301 |
Celeste PALLANT |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #301 |
Peter Tasco |
— |
1 |